The APROVE (Anti-coagulation/platelet treatment in pancreatic resections involving vascular reconstruction) study: results from a worldwide survey
Background: Antithrombotic therapy (AT) aims to strike a balance between preventing thromboembolic and hemorrhagic complications. However, evidence for AT management after pancreatectomy with vascular reconstruction is lacking. We aimed to provide an overview of the current use of AT for pancreatic...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
30 June 2025
|
| In: |
Annals of surgical oncology
Year: 2025, Jahrgang: 32, Heft: 10, Pages: 7400-7409 |
| ISSN: | 1534-4681 |
| DOI: | 10.1245/s10434-025-17686-y |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1245/s10434-025-17686-y
|
| Verfasserangaben: | Alessio Marchetti, MD, Jonathan Garnier, MD, PhD, Joseph R. Habib, MD, Ingmar F. Rompen, MD, Paul C.M. Andel, MD, Camila Hidalgo Salinas, MD, Molly Ratner, MD, Matteo De Pastena, MD, PhD, Roberto Salvia, MD, PhD, D. Brock Hewitt, MD, MPH, Katherine Morgan, MD, Michael D. Kluger, MD, MPH, Karan Garg, MD, Ammar A. Javed, MD, Christopher L. Wolfgang, MD, PhD, and Greg D. Sacks, MD, MPH, PhD |
MARC
| LEADER | 00000naa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 194033232X | ||
| 003 | DE-627 | ||
| 005 | 20251105132551.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 251105s2025 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1245/s10434-025-17686-y |2 doi | |
| 035 | |a (DE-627)194033232X | ||
| 035 | |a (DE-599)KXP194033232X | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Marchetti, Alessio |e VerfasserIn |0 (DE-588)1380825571 |0 (DE-627)1940332869 |4 aut | |
| 245 | 1 | 4 | |a The APROVE (Anti-coagulation/platelet treatment in pancreatic resections involving vascular reconstruction) study |b results from a worldwide survey |c Alessio Marchetti, MD, Jonathan Garnier, MD, PhD, Joseph R. Habib, MD, Ingmar F. Rompen, MD, Paul C.M. Andel, MD, Camila Hidalgo Salinas, MD, Molly Ratner, MD, Matteo De Pastena, MD, PhD, Roberto Salvia, MD, PhD, D. Brock Hewitt, MD, MPH, Katherine Morgan, MD, Michael D. Kluger, MD, MPH, Karan Garg, MD, Ammar A. Javed, MD, Christopher L. Wolfgang, MD, PhD, and Greg D. Sacks, MD, MPH, PhD |
| 264 | 1 | |c 30 June 2025 | |
| 300 | |b Illustrationen | ||
| 300 | |a 10 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Veröffentlicht: 30. Juni 2025 | ||
| 500 | |a Gesehen am 05.11.2025 | ||
| 520 | |a Background: Antithrombotic therapy (AT) aims to strike a balance between preventing thromboembolic and hemorrhagic complications. However, evidence for AT management after pancreatectomy with vascular reconstruction is lacking. We aimed to provide an overview of the current use of AT for pancreatic surgery with vascular reconstructions. Patients and Methods: A web-based survey was distributed to 123 surgeons from high-volume pancreas centers (>50 pancreatic resections/year). AT management after different types of vascular reconstruction were investigated. An “aggressive” protocol was defined as the use of any AT protocol other than prophylactic heparin, aspirin, or their combination. Results: The survey was completed by 80 surgeons (59% Europe, 30% USA, 11% Asia). In Europe/Asia, prophylactic heparin was the most commonly reported protocol after partial venous resection/end-to-end anastomosis/human graft (71%/65%/50%, respectively), and an “aggressive” protocol (86%) was the most frequently used after prosthetic graft reconstruction. Conversely, in the USA, prophylactic heparin + aspirin was the most commonly reported protocol after all types of venous reconstruction. Following arterial reconstruction, heparin + aspirin was the most commonly reported protocol, regardless of region. An “aggressive” protocol was more frequently used in Europe/Asia (odds ratio (OR) 1.28; p < 0.001) and following vein reconstruction with either human graft (OR 1.2; p = 0.007) or prosthetic graft (OR 1.56, p <0.001), while ultrasound (OR 1.65; p < 0.001) and arterial reconstruction (OR 1.64; p < 0.001) were significantly associated with antiplatelet use. Conclusions: In an international cohort of high-volume pancreas surgeons, significant variation in the use of AT following pancreatectomy with vascular reconstruction was observed. This variation was driven by geographical differences and the type of vascular reconstructions performed. | ||
| 650 | 4 | |a Anticoagulants | |
| 650 | 4 | |a Antiplatelets | |
| 650 | 4 | |a Antithrombotic therapy | |
| 650 | 4 | |a Pancreatic surgery | |
| 650 | 4 | |a Vascular reconstruction | |
| 700 | 1 | |a Garnier, Jonathan |e VerfasserIn |4 aut | |
| 700 | 1 | |a Habib, Joseph R. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Rompen, Ingmar F. |d 1994- |e VerfasserIn |0 (DE-588)1260414086 |0 (DE-627)1807281671 |4 aut | |
| 700 | 1 | |a Andel, Paul C. M. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Salinas, Camila Hidalgo |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ratner, Molly |e VerfasserIn |4 aut | |
| 700 | 1 | |a De Pastena, Matteo |e VerfasserIn |4 aut | |
| 700 | 1 | |a Salvia, Roberto |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hewitt, D. Brock |e VerfasserIn |4 aut | |
| 700 | 1 | |a Morgan, Katherine |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kluger, Michael D. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Garg, Karan |e VerfasserIn |4 aut | |
| 700 | 1 | |a Javed, Ammar A. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Wolfgang, Christopher L. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Sacks, Greg D. |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annals of surgical oncology |d Berlin [u.a.] : Springer, 1994 |g 32(2025), 10, Seite 7400-7409 |h Online-Ressource |w (DE-627)343969947 |w (DE-600)2074021-9 |w (DE-576)099879212 |x 1534-4681 |7 nnas |a The APROVE (Anti-coagulation/platelet treatment in pancreatic resections involving vascular reconstruction) study results from a worldwide survey |
| 773 | 1 | 8 | |g volume:32 |g year:2025 |g number:10 |g pages:7400-7409 |g extent:10 |a The APROVE (Anti-coagulation/platelet treatment in pancreatic resections involving vascular reconstruction) study results from a worldwide survey |
| 856 | 4 | 0 | |u https://doi.org/10.1245/s10434-025-17686-y |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20251105 | ||
| 993 | |a Article | ||
| 994 | |a 2025 | ||
| 998 | |g 1260414086 |a Rompen, Ingmar F. |m 1260414086:Rompen, Ingmar F. |d 910000 |d 910200 |e 910000PR1260414086 |e 910200PR1260414086 |k 0/910000/ |k 1/910000/910200/ |p 4 | ||
| 999 | |a KXP-PPN194033232X |e 4797191155 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Veröffentlicht: 30. Juni 2025","Gesehen am 05.11.2025"],"recId":"194033232X","language":["eng"],"title":[{"subtitle":"results from a worldwide survey","title":"The APROVE (Anti-coagulation/platelet treatment in pancreatic resections involving vascular reconstruction) study","title_sort":"APROVE (Anti-coagulation/platelet treatment in pancreatic resections involving vascular reconstruction) study"}],"person":[{"display":"Marchetti, Alessio","roleDisplay":"VerfasserIn","role":"aut","family":"Marchetti","given":"Alessio"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Garnier, Jonathan","given":"Jonathan","family":"Garnier"},{"display":"Habib, Joseph R.","roleDisplay":"VerfasserIn","role":"aut","family":"Habib","given":"Joseph R."},{"role":"aut","display":"Rompen, Ingmar F.","roleDisplay":"VerfasserIn","given":"Ingmar F.","family":"Rompen"},{"roleDisplay":"VerfasserIn","display":"Andel, Paul C. M.","role":"aut","family":"Andel","given":"Paul C. M."},{"family":"Salinas","given":"Camila Hidalgo","roleDisplay":"VerfasserIn","display":"Salinas, Camila Hidalgo","role":"aut"},{"display":"Ratner, Molly","roleDisplay":"VerfasserIn","role":"aut","family":"Ratner","given":"Molly"},{"given":"Matteo","family":"De Pastena","role":"aut","display":"De Pastena, Matteo","roleDisplay":"VerfasserIn"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Salvia, Roberto","given":"Roberto","family":"Salvia"},{"role":"aut","display":"Hewitt, D. Brock","roleDisplay":"VerfasserIn","given":"D. Brock","family":"Hewitt"},{"roleDisplay":"VerfasserIn","display":"Morgan, Katherine","role":"aut","family":"Morgan","given":"Katherine"},{"given":"Michael D.","family":"Kluger","role":"aut","roleDisplay":"VerfasserIn","display":"Kluger, Michael D."},{"family":"Garg","given":"Karan","display":"Garg, Karan","roleDisplay":"VerfasserIn","role":"aut"},{"display":"Javed, Ammar A.","roleDisplay":"VerfasserIn","role":"aut","family":"Javed","given":"Ammar A."},{"display":"Wolfgang, Christopher L.","roleDisplay":"VerfasserIn","role":"aut","family":"Wolfgang","given":"Christopher L."},{"given":"Greg D.","family":"Sacks","role":"aut","display":"Sacks, Greg D.","roleDisplay":"VerfasserIn"}],"physDesc":[{"noteIll":"Illustrationen","extent":"10 S."}],"relHost":[{"origin":[{"dateIssuedKey":"1994","publisher":"Springer ; Lippincott Williams & Wilkins","dateIssuedDisp":"1994-","publisherPlace":"Berlin [u.a.] ; Philadelphia, Pa."}],"id":{"eki":["343969947"],"zdb":["2074021-9"],"issn":["1534-4681"]},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"Annals of surgical oncology","title":"Annals of surgical oncology","subtitle":"the official journal of the Society of Surgical Oncology"}],"note":["Gesehen am 26.09.25"],"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"The APROVE (Anti-coagulation/platelet treatment in pancreatic resections involving vascular reconstruction) study results from a worldwide surveyAnnals of surgical oncology","language":["eng"],"corporate":[{"roleDisplay":"Herausgebendes Organ","display":"Society of Surgical Oncology","role":"isb"}],"recId":"343969947","pubHistory":["1.1994 -"],"part":{"year":"2025","issue":"10","pages":"7400-7409","text":"32(2025), 10, Seite 7400-7409","volume":"32","extent":"10"}}],"origin":[{"dateIssuedDisp":"30 June 2025","dateIssuedKey":"2025"}],"id":{"doi":["10.1245/s10434-025-17686-y"],"eki":["194033232X"]},"name":{"displayForm":["Alessio Marchetti, MD, Jonathan Garnier, MD, PhD, Joseph R. Habib, MD, Ingmar F. Rompen, MD, Paul C.M. Andel, MD, Camila Hidalgo Salinas, MD, Molly Ratner, MD, Matteo De Pastena, MD, PhD, Roberto Salvia, MD, PhD, D. Brock Hewitt, MD, MPH, Katherine Morgan, MD, Michael D. Kluger, MD, MPH, Karan Garg, MD, Ammar A. Javed, MD, Christopher L. Wolfgang, MD, PhD, and Greg D. Sacks, MD, MPH, PhD"]}} | ||
| SRT | |a MARCHETTIAAPROVEANTI3020 | ||